Collaborations & Partnerships
DiscoveRx Management encourages collaborations with a host of pharmaceutical companies, academic institutes, biotech vendors and service providers as well
as assay development organizations. We recognize that the
β-galactosidase based Enzyme Fragment Technology and products have vast potential and cannot
be addressed by
one business model or organization alone. We seek to learn from the work of others and share our experience and expertise with others in the field.
Please contact skuchibhatla@discoverx.com for any the following opportunities.
•Drug Discovery Partnerships
•Strategic Collaborations and Alliances
•Distribution Opportunities
•Product Development Collaboration
Evotec offers services and integrated drug discovery alliances based on its state-of-the-art technology platform and a broad range of integrated capabilities spanning the drug discovery process. Evotec differentiates itself based on a strong track record in drug discovery, scientists with core expertise along the entire drug discovery and development process, combined with disease biology expertise spanning CNS, inflammation, pain and oncology.
Evotec's platform and capabilities integrate the following areas of expertise
•
Integrated drug discovery
•
Assay development and screening
•
Fragment based drug discovery
•
Medicinal chemistry and early development
•
ADMET and zebrafish testing
The combination of EFC-based PathHunter™ and HitHunter™ cAMP assays technologies with Evotec's proprietary platform, high quality compound
collection and know-how in high throughput screening means that Evotec can now offer unrivalled screening solutions for GPCRs and other important target
classes. For more information on Evotec and its service offering, please visit www.evotec.com